AcquisitionsMay 21, 2026, 06:57 AM
Wellgistics Health to form DelivMeds AI with $4B combined asset value
AI Summary
Wellgistics Health, Inc. entered into a binding term sheet to form DelivMeds AI, Inc., a new healthcare company with an expected combined asset value of $4 billion. This involves acquiring QOLPOM intellectual property from EOS Technology Holdings and Scilex Holding Company, expanding its PharmacyChain license with Datavault AI, and acquiring a controlling interest in Tollo Health, LLC. Additionally, the company announced a 1-for-50 reverse stock split to regain Nasdaq compliance and amended a note purchase agreement, increasing the principal to $1.5 million. Gerald Commissiong was also appointed Interim Co-CEO.
Key Highlights
- Wellgistics Health to form DelivMeds AI with an expected $4 billion combined asset value.
- Acquiring QOLPOM IP from EOS and Scilex, and expanding PharmacyChain license with Datavault AI.
- Acquiring a controlling interest in Tollo Health, LLC from HealthBridge Advisors.
- Post-conversion, EOS, Scilex, Datavault, Fortitude, and HBA to own 89.6% of common stock.
- Targeting a concurrent minimum investment of $2.0 million from Dawson James investors.
- Approved a 1-for-50 reverse stock split to regain Nasdaq minimum bid price compliance.
- Amended a note purchase agreement, increasing the principal amount to $1.5 million.
- Gerald Commissiong appointed Interim Co-CEO of Wellgistics Health.
Price Impact
More from WGRX